Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer

NCT00074152 ·Status: COMPLETED ·Phase: PHASE3

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

NCT00053911 ·Status: TERMINATED ·Phase: PHASE3

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

NCT00001250 ·Status: COMPLETED ·Phase: PHASE2

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

NCT00603408 ·Status: TERMINATED ·Phase: PHASE2

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

NCT00191438 ·Status: COMPLETED ·Phase: PHASE3

Predictive Model of Therapy Outcomes in Breast Cancer Patients

NCT01563211 ·Status: COMPLETED

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

NCT06621459 ·Status: RECRUITING

Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine

NCT00294385 ·Status: COMPLETED ·Phase: PHASE3

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

NCT02401685 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic

NCT00003440 ·Status: COMPLETED ·Phase: PHASE3

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

NCT00201435 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

NCT00003095 ·Status: COMPLETED

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

NCT03423849 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

NCT04130750 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Breast Cancer Treated by Neoadjuvant Chemotherapy

NCT00425516 ·Status: COMPLETED ·Phase: PHASE2

Study of Neoadjuvant Chemotherapy of Breast Cancer

NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2

Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer

NCT04809844 ·Status: UNKNOWN

Cisplatin + RT for Triple Negative Breast Cancer

NCT01674842 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer

NCT01351597 ·Status: UNKNOWN ·Phase: PHASE2

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

NCT00006120 ·Status: UNKNOWN ·Phase: PHASE2

Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer

NCT00461344 ·Status: TERMINATED ·Phase: PHASE2

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

NCT03201861 ·Status: RECRUITING ·Phase: PHASE3

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

NCT00470236 ·Status: UNKNOWN ·Phase: NA

Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

NCT00155259 ·Status: COMPLETED ·Phase: PHASE2

Intraoperative Radiotherapy After Local Recurrence in Breast Cancer

NCT02386371 ·Status: COMPLETED ·Phase: NA